These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23035074)

  • 1. Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
    Gross CM; Baumgartner A; Rauer S; Stich O
    Neurology; 2012 Nov; 79(19):2006-7. PubMed ID: 23035074
    [No Abstract]   [Full Text] [Related]  

  • 2. Fingolimod and multiple sclerosis: four cautionary tales.
    Bourdette D; Gilden D
    Neurology; 2012 Nov; 79(19):1942-3. PubMed ID: 23035058
    [No Abstract]   [Full Text] [Related]  

  • 3. Rebound of disease activity during pregnancy after withdrawal of fingolimod.
    Sempere AP; Berenguer-Ruiz L; Feliu-Rey E
    Eur J Neurol; 2013 Aug; 20(8):e109-10. PubMed ID: 23829238
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.
    Conzett KB; Kolm I; Jelcic I; Kamarachev J; Dummer R; Braun R; French LE; Linnebank M; Hofbauer GF
    Arch Dermatol; 2011 Aug; 147(8):991-2. PubMed ID: 21844470
    [No Abstract]   [Full Text] [Related]  

  • 5. Fingolimod for multiple sclerosis.
    Pelletier D; Hafler DA
    N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
    Ricklin ME; Lorscheider J; Waschbisch A; Paroz C; Mehta SK; Pierson DL; Kuhle J; Fischer-Barnicol B; Sprenger T; Lindberg RL; Kappos L; Derfuss T
    Neurology; 2013 Jul; 81(2):174-81. PubMed ID: 23700335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingolimod: cardiovascular deaths.
    Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fingolimod treatment in multiple sclerosis].
    Tanaka M
    Nihon Rinsho; 2014 Nov; 72(11):2010-4. PubMed ID: 25518386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?
    Castrop F; Kowarik MC; Albrecht H; Krause M; Haslinger B; Zimmer C; Berthele A; Hemmer B
    Neurology; 2012 Mar; 78(12):928-30. PubMed ID: 22402856
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
    JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral fingolimod (gilenya) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
    Lysandropoulos AP; Benghiat F
    Mult Scler; 2013 Oct; 19(11):1551-2. PubMed ID: 23817558
    [No Abstract]   [Full Text] [Related]  

  • 13. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.
    Gallego-Pinazo R; España-Gregori E; Casanova B; Pardo-López D; Díaz-Llopis M
    J Neuroophthalmol; 2011 Sep; 31(3):292-3. PubMed ID: 21826025
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed fingolimod-associated asystole.
    Espinosa PS; Berger JR
    Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
    Cohen JA; Barkhof F; Comi G; Hartung HP; Khatri BO; Montalban X; Pelletier J; Capra R; Gallo P; Izquierdo G; Tiel-Wilck K; de Vera A; Jin J; Stites T; Wu S; Aradhye S; Kappos L;
    N Engl J Med; 2010 Feb; 362(5):402-15. PubMed ID: 20089954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
    Leypoldt F; Münchau A; Moeller F; Bester M; Gerloff C; Heesen C
    Neurology; 2009 Mar; 72(11):1022-4. PubMed ID: 19289744
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
    Rolf L; Muris AH; Damoiseaux J; van Daele M; Hupperts R
    Neurology; 2014 Mar; 82(11):1008-9. PubMed ID: 24523479
    [No Abstract]   [Full Text] [Related]  

  • 18. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
    Komoly S
    Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary varicella zoster infection associated with fingolimod treatment.
    Uccelli A; Ginocchio F; Mancardi GL; Bassetti M
    Neurology; 2011 Mar; 76(11):1023-4. PubMed ID: 21403115
    [No Abstract]   [Full Text] [Related]  

  • 20. Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
    Piscolla E; Hakiki B; Pastò L; Razzolini L; Portaccio E; Amato MP
    J Neurol; 2013 Jun; 260(6):1675-7. PubMed ID: 23645219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.